ATCvet code QP51

ATC codes

P Antiparasitic products, insecticides and repellents

Human only

P01 Antiprotozoals

P02 Anthelmintics

P03 Ectoparasiticides, including scabicides, insecticides and repellents

ATCvet only

QP51 Antiprotozoals

QP52 Anthelmintics

QP53 Ectoparasiticides, including insecticides and repellents

QP54 Endectocides

A
B
C
D
G
H
QI
J
L
M
N
P
R
S
V

ATCvet code QP51 Antiprotozoals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System for veterinary medicinal products, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products for veterinary use. Subgroup QP51 is part of the anatomical group QP Antiparasitic products, insecticides and repellents.^[1]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

QP51A Agents against protozoal diseases

QP51AA Nitroimidazole derivatives

QP51AA01 Metronidazole

QP51AA02 Tinidazole

QP51AA03 Ornidazole

QP51AA04 Azanidazole

QP51AA05 Propenidazole

QP51AA06 Nimorazole

QP51AA07 Dimetridazole

QP51AA08 Ronidazole

QP51AA09 Carnidazole

QP51AA10 Ipronidazole

QP51AB Antimony compounds

QP51AB01 Meglumine antimonate

QP51AB02 Sodium stibogluconate

QP51AC Nitrofuran derivatives

QP51AC01 Nifurtimox

QP51AC02 Nitrofural

QP51AD Arsenic compounds

QP51AD01 Arsthinol

QP51AD02 Difetarsone

QP51AD03 Glycobiarsol

QP51AD04 Melarsoprol

QP51AD05 Acetarsol

QP51AD06 Melarsamin

QP51AD53 Glycobiarsol, combinations

QP51AE Carbanilides

QP51AE01 Imidocarb

QP51AE02 Suramin sodium

QP51AE03 Nicarbazine

QP51AF Aromatic diamidines

QP51AF01 Diminazen

QP51AF02 Pentamidine

QP51AF03 Phenamidine

QP51AG Sulfonamides, plain and in combinations

QP51AG01 Sulfadimidine

QP51AG02 Sulfadimethoxine

QP51AG03 Sulfaquinoxaline

QP51AG04 Sulfaclozine

QP51AG30 Combinations of sulfonamides

QP51AG51 Sulfadimidine, combinations

QP51AG53 Sulfaquinoxaline, combinations

QP51AH Pyranes and hydropyranes

QP51AH01 Salinomycin

QP51AH02 Lasalocid

QP51AH03 Monensin

QP51AH04 Narasin

QP51AH54 Narasin, combinations

QP51AJ Triazines

QP51AJ01 Toltrazuril

QP51AJ02 Clazuril

QP51AJ03 Diclazuril

QP51AJ04 Ponazuril

QP51AX Other antiprotozoal agents

QP51AX01 Chiniofon

QP51AX02 Emetine

QP51AX03 Phanquinone

QP51AX04 Mepacrine

QP51AX05 Nifursol

QP51AX06 Homidium

QP51AX07 Diminazen

QP51AX08 Halofuginone

QP51AX09 Amprolium

QP51AX10 Maduramicin

QP51AX11 Arprinocid

QP51AX12 Dinitolmide

QP51AX13 Robenidine

QP51AX14 Decoquinate

QP51AX16 Aminonitrothiazol

QP51AX17 Ethopabate

QP51AX18 Diaveridine

QP51AX19 Isometamidium

QP51AX20 Quinapyramine

QP51AX21 Parvaquone

QP51AX22 Buparvaquone

QP51AX23 Fumagillin

QP51AX24 Domperidone

QP51AX30 Combinations of other protozoal agents

QP51AX51 Pyrimethamine, combinations

QP51AX59 Amprolium, combinations

QP51B Agents against coccidiosis – optional classification

Empty group

QP51C Agents against amoebiosis and histomonosis – optional classification

Empty group

QP51D Agents against leishmaniosis and trypanosomosis – optional classification

Empty group

QP51E Agents against babesiosis and theileriosis – optional classification

Empty group

QP51X Other antiprotozoal agents – optional classification

Empty group

References

↑ "ATCvet Index 2016: code QP51". WHO Collaborating Centre for Drug Statistics Methodology.

Antiparasitics – antiprotozoal agents – Chromalveolate antiparasitics (P01)

Conoidasida/
(Coccidiostats)

Cryptosporidiosis	thiazolide (nitazoxanide)

Isosporiasis	trimethoprim/sulfamethoxazole^#

Toxoplasmosis	pyrimethamine sulfadiazine

Individual
agents

Hemozoin
inhibitors

aminoquinolines	(4-): amodiaquine^# chloroquine^# Tafenoquine (8-): primaquine^# pamaquine

4-methanolquinolines	mefloquine^# quinine^# quinidine

Other	lumefantrine combined with artemether halofantrine

DHFR inhibitors (antifols)	pyrimethamine proguanil^# chlorproguanil biguanides

Sulfonamides	sulfadoxine sulfamethoxypyrazine

Coformulation	sulfadoxine/pyrimethamine (SP)^#

Sesquiterpene
lactones

Other

Combi-
nations

Fixed-dose (coformulated) ACTs	artemether/lumefantrine^# artesunate/amodiaquine (ASAQ) artesunate/mefloquine (ASMQ) dihydroartemisinin/piperaquine artesunate/pyronaridine

Other combinations (not co-formulated)	artesunate/SP artesunate/mefloquine quinine/tetracycline quinine/doxycycline quinine/clindamycin

clindamycin

Balantidiasis: Tetracycline

Blastocystosis: Metronidazole

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Antiparasitics – antiprotozoal agents – agents against amoebozoa/amebicide (P01)

Tissue amebicides

Nitroimidazole derivatives	Metronidazole^# Tinidazole Ornidazole Nimorazole Secnidazole Azanidazole Propenidazole

Other	isoquinoline (Emetine/Dehydroemetine)

Luminal amebicides

Hydroxyquinoline derivatives	Cl (Chlorquinaldol) Br (Tilbroquinol Broxyquinoline) I (Diiodohydroxyquinoline) I, Cl (Clioquinol) related: Chiniofon

Dichloroacetamide derivatives	Diloxanide^# Clefamide Etofamide Teclozan

Aminoglycoside	Paromomycin

Other/ungrouped

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This article is issued from Wikipedia - version of the Saturday, December 21, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.